Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It has been developed using Novo Nordisks proprietary protein-acylation technology, and is administered using an injection device
Key differences from injections: Easier administration (no needles) Slightly slower or less efficient absorption for some users Still effective but may require more consistent daily use Understanding these formats helps you match the product to your comfort level and lifestyle
In the Phase 3 REDEFINE 1 trial, adults without type 2 diabetes lost an average of 22.7% of their body weight over 68 weeks
We can discuss the different benefits of each treatment option with you
A healthcare provider can help weigh the risks and benefits based on personal health situations
